SAB Biotherapeutics SABS
NASDAQ SABS
$2.90 +0.02 (+0.69%)
As of: Oct 21, 2026 · 11:03 AM EDT

SAB Biotherapeutics (SABS) Current Taxes (2022)

Updated

SAB Biotherapeutics (SABS) recorded Current Taxes of $92,281 in Q1 2022.

Analysis

SAB Biotherapeutics (SABS) Current Taxes (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,131.80 Bn 1,100.39 Bn 19.71 Bn -
2 Johnson & Johnson 614.01 Bn 532.53 Bn 17.26 Bn 1.05 Bn
3 AbbVie 503.59 Bn 476.70 Bn 12.70 Bn -
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn 4.22 Bn
5 Novartis Ag 297.81 Bn 261.80 Bn 11.24 Bn 2.31 Bn
6 Astrazeneca 261.50 Bn 235.19 Bn 12.86 Bn 1.47 Bn
7 Amgen 236.24 Bn 191.64 Bn 7.24 Bn -
8 Gilead Sciences 191.15 Bn 165.35 Bn 6.22 Bn -
9 Pfizer 170.16 Bn 116.81 Bn 10.94 Bn 653.00 Mn
10 SAB Biotherapeutics 232.08 Mn -185.42 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2022 92,281.00
API Access

SAB Biotherapeutics Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=SABS&period=max&api_key=YOUR_API_KEY